| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2016 | PCRX Pacira Biosciences, Inc. | Jones James B | SVP &Chief Medical Officer | Buy | 1,000 | $66.00 | $66,000.00 | New | |
| Jan 12, 2016 | PCRX Pacira Biosciences, Inc. | Longenecker John P Phd | Director | Buy | 300 | $66.55 | $19,964.70 | +15.0% | |
| Jan 12, 2016 | SNY Sanofi | Sanofi | 10% Owner | Buy | 83,938 | $465.04 | $39,034,660.20 | - | |
| Jan 8, 2016 | PAHC Phibro Animal Health Corp | Miller Larry Lee | President | Sell | 4,303 | $30.03 | $129,219.09 | -100% | |
| Jan 6, 2016 | PRGO Perrigo Co Plc | Brown Judy L | Executive VP &CFO | Sell | 27,737 | $142.41 | $3,950,075.36 | -35.8% | |
| Jan 6, 2016 | PAHC Phibro Animal Health Corp | Miller Larry Lee | President | Sell | 4,472 | $30.10 | $134,616.00 | -100% | |
| Jan 6, 2016 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 8,056 | $30.01 | $241,793.22 | -3.5% | |
| Jan 6, 2016 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 8,056 | $30.01 | $241,793.22 | -3.5% | |
| Jan 4, 2016 | EGRX Eagle Pharmaceuticals, Inc. | Tarriff Scott | President And CEO | Sell | 14,549 | $85.91 | $1,249,920.86 | -0.5% | |
| Jan 4, 2016 | EBS Emergent Biosolutions Inc. | Bailey Sue | Director | Sell | 11,520 | $38.79 | $446,889.60 | -11.9% | |
| Jan 4, 2016 | AKBA Akebia Therapeutics, Inc. | Hadas Nicole R.60 | SVP, General Counsel, Sec. | Sell | 1,811 | $12.28 | $22,239.08 | -2.7% | |
| Dec 30, 2015 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 21,600 | $40.00 | $864,000.00 | -61.1% | |
| Dec 30, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 12,000 | $30.49 | $365,840.00 | -5.4% | |
| Dec 30, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 12,000 | $30.49 | $365,840.00 | -5.4% | |
| Dec 28, 2015 | PRGO Perrigo Co Plc | Papa Joseph C | CEO | Sell | 10,183 | $147.07 | $1,497,579.17 | -4.1% | |
| Dec 24, 2015 | EBS Emergent Biosolutions Inc. | Abdun-Nabi Daniel | President &CEO | Sell | 63,209 | $39.06 | $2,468,632.81 | -14.6% | |
| Dec 23, 2015 | PAHC Phibro Animal Health Corp | Carlson Gerald K | Chief Operating Officer | Sell | 11,077 | $31.38 | $347,585.60 | -100% | |
| Dec 22, 2015 | EGRX Eagle Pharmaceuticals, Inc. | Flaum Sander A | Director | Sell | 13,025 | $54.81 | $713,959.88 | -26.6% | |
| Dec 21, 2015 | BCRX Biocryst Pharmaceuticals Inc | Staab Thomas R II | Senior Vice President And CFO | Sell | 3,052 | $10.86 | $33,144.72 | -2.2% | |
| Dec 21, 2015 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 205,000 | $86.00 | $17,630,000.00 | -0.2% | |
| Dec 18, 2015 | ANIP Ani Pharmaceuticals Inc | Marken James G.47 | Vice President, Operations | Sell | 3,500 | $43.26 | $151,410.00 | -7.1% | |
| Dec 18, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 12,000 | $31.83 | $381,920.00 | -5.4% | |
| Dec 18, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 12,000 | $31.83 | $381,920.00 | -5.4% | |
| Dec 17, 2015 | BCRX Biocryst Pharmaceuticals Inc | Staab Thomas R II | Senior Vice President And CFO | Sell | 3,000 | $10.49 | $31,470.00 | -2.1% | |
| Dec 17, 2015 | AMPH Amphastar Pharmaceuticals, Inc. | Zasloff Michael A53 | Director | Sell | 30,770 | $14.20 | $436,853.27 | -36.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.